Human Genome Epidemiology Literature Finder
|
Records 1 - 10 (of 10 Records) |
| Query Trace: Thymoma and EGFR[original query] |
|---|
| AKT1 and AKT2 mutations in lung cancer in a Japanese population. Molecular medicine reports 0 1 (5): 663-6. Sasaki Hidefumi, Okuda Katsuhiro, Kawano Osamu, Yukiue Haruhiro, Yano Motoki, Fujii Yoshita |
| MEK1 and AKT2 mutations in Japanese lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010 Mar . Sasaki H, Hikosaka Y, Kawano O, Moriyama S, Yano M, Fujii Y |
| Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma-rationale for comprehensive mutation profiling. Molecular cancer therapeutics 2012 Feb 11 (2): 485-91. Chaft Jamie E, Arcila Maria E, Paik Paul K, Lau Christopher, Riely Gregory J, Pietanza M Catherine, Zakowski Maureen F, Rusch Valerie, Sima Camelia S, Ladanyi Marc, Kris Mark |
| A targeted next-generation sequencing assay detects a high frequency of therapeutically targetable alterations in primary and metastatic breast cancers: implications for clinical practice. The oncologist 2014 May 19 (5): 453-8. Vasan Neil, Yelensky Roman, Wang Kai, Moulder Stacy, Dzimitrowicz Hannah, Avritscher Rony, Wang Baliang, Wu Yun, Cronin Maureen T, Palmer Gary, Symmans W Fraser, Miller Vincent A, Stephens Philip, Pusztai Laj |
| Molecular genetic alterations in egfr CA-SSR-1 microsatellite and egfr copy number changes are associated with aggressiveness in thymoma. Journal of thoracic disease 2016 Mar 8 (3): 386-95. Conti Salvatore, Gallo Enzo, Sioletic Stefano, Facciolo Francesco, Palmieri Giovannella, Lauriola Libero, Evoli Amelia, Martucci Robert, Di Benedetto Anna, Novelli Flavia, Giannarelli Diana, Deriu Gloria, Granone Pierluigi, Ottaviano Margaret, Muti Paola, Pescarmona Edoardo, Marino Mirel |
| Rare frequency of gene variation and survival analysis in thymic epithelial tumors. OncoTargets and therapy 2016 9 6337-6342. Song Zhengbo, Yu Xinmin, Zhang Yipi |
| Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs). Lung cancer (Amsterdam, Netherlands) 2017 Feb 104 24-30. Tiseo Marcello, Damato Angela, Longo Lucia, Barbieri Fausto, Bertolini Federica, Stefani Alessandro, Migaldi Mario, Gnetti Letizia, Camisa Roberta, Bordi Paola, Buti Sebastiano, Rossi Giul |
| A mutation analysis of the EGFR pathway genes, RAS, EGFR, PIK3CA, AKT1 and BRAF, and TP53 gene in thymic carcinoma and thymoma type A/B3. Histopathology 2019 Jun . Sakane Tadashi, Murase Takayuki, Okuda Katsuhiro, Saida Kosuke, Masaki Ayako, Yamada Takeshi, Saito Yushi, Nakanishi Ryoichi, Inagaki Hiros |
| TP53 and EGFR Mutational Status in Thymoma: A Genetic Sequencing Study. Asian Pacific journal of cancer prevention : APJCP 2022 1 23 (1): 109-114. Syahruddin Elisna, Zaini Jamal, Sembiring Ruth, Baginta Romi, Fadhillah Muhammad Rizqy, Noor Dimas Ramadhi |
| Clinicogenomic Landscape of Metastatic Thymic Epithelial Tumors. JCO precision oncology 2023 2 7 e2200465. Ardeshir-Larijani Fatemeh, Schneider Bryan P, Althouse Sandra K, Radovich Milan, Masood Ashiq, Perna Fabiana, Salman Huda, Loehrer Patrick |
- Page last reviewed:Feb 1, 2024
- Content source: